New York · 2025 Regular Session · Bill

S 6466: Authorizes reimbursement for testing for familial dysautonomia, Canavan's disease and Tay-Sachs

In committee Last action January 7, 2026: REFERRED TO INSURANCE

Plain-language summary

S 6466 is a bill introduced in the New York Senate on March 14, 2025. According to its official title, it concerns: Authorizes reimbursement for testing for familial dysautonomia, Canavan's disease and Tay-Sachs. Primary sponsor: Cordell Cleare (Democratic). Most recent recorded action (January 7, 2026): REFERRED TO INSURANCE.

Sponsors

Primary sponsor: Cordell Cleare (Democratic).